Mariani John J, Levin Frances R
New York State Psychiatric Institute, New York, New York, USA.
Am J Addict. 2007;16 Suppl 1(Suppl 1):45-54; quiz 55-6. doi: 10.1080/10550490601082783.
Attention-deficit hyperactivity disorder (ADHD) is a common co-occurring mental disorder among patients with substance use disorders (SUD). Clinicians must be cognizant of the complicated nature of diagnosis and treatment of ADHD when comorbid with SUD. Pharmacotherapy remains the mainstay of treatment for ADHD, although complementary psychotherapeutic approaches have been developed. Psychostimulant medications are the most commonly used medications to treat ADHD, but many clinicians are reluctant to prescribe stimulants to patients with SUD. Recommendations for treatment planning and clinical management for patients with co-occurring ADHD and SUD are discussed.
注意缺陷多动障碍(ADHD)是物质使用障碍(SUD)患者中常见的共病精神障碍。临床医生在面对ADHD与SUD共病情况时,必须认识到其诊断和治疗的复杂性。药物治疗仍然是ADHD治疗的主要方法,尽管也已开发出辅助心理治疗方法。精神刺激药物是治疗ADHD最常用的药物,但许多临床医生不愿给患有SUD的患者开此类药物。本文讨论了ADHD与SUD共病患者的治疗计划和临床管理建议。